Given the current situation, we understand that people may experience worry and even fear about how their disease and treatment may impact their personal risk. Sanofi Genzyme is committed to patient safety and to transparent communication. We are taking COVID-19 seriously, and we are committed to updating the communities we serve with relevant information related to our medicines to help inform health decisions.
As COVID-19 has emerged only recently, there are no available data regarding the impact of the virus on our current therapies. At this time, if you have general questions about our therapies, you should consult the current U.S Prescribing Information (USPI).
Each patient’s situation is unique, and patients and their healthcare providers are in the best position to make decisions regarding their care. In addition to local public health authority guidance, and local guidance from medical or patient associations, more information about COVID-19 can be found on the Centers for Disease Control’s (CDC) website or the World Health Organization’s (WHO) website.
MAT-US-2001107
INDICATION
AUBAGIO® (teriflunomide) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Do not take AUBAGIO if you have severe liver problems, are pregnant or of childbearing potential and not using effective birth control, have had an allergic reaction to AUBAGIO or leflunomide, or are taking a medicine called leflunomide for rheumatoid arthritis. View IMPORTANT SAFETY INFORMATION
Patient Portrayal
RELAPSING MS IS A JOURNEY, AND EVERYONE’S IS DIFFERENT.
Your MS is unique, and your treatment needs will naturally change over time. When choosing your first treatment, you’ll want to work with your healthcare provider to make sure you’re as comfortable as possible with this decision. If you’re already on a treatment, it’s normal to reflect on this experience and take advantage of all you’ve learned.
When you’re just starting out on your MS journey, you have a million questions. And some of them are very basic: What is relapsing MS? Is there a cure for it? How is MS treated? You can find answers to these and other questions in our FAQs.
But when it comes to choosing a treatment, sometimes it’s the questions you ask yourself that matter most. Here are 6 smart questions that could help you decide what’s next:
- How do I want to take my relapsing MS treatment?
- Today you have many choices including injectables, infusions, and pills.
- LEARN ABOUT A ONCE-DAILY PILL
- Is a long-term safety profile important to me?
- Safety of any medication is an important consideration in your treatment decision.
- FIND OUT ABOUT AUBAGIO’S 15-YEAR SAFETY HISTORY
- Do I know the effectiveness of the options I’m considering?
- AUBAGIO was studied against three key goals of relapsing MS treatment.
- SEE HOW AUBAGIO PERFORMED IN CLINICAL TRIALS
- Am I ready to begin a relapsing MS treatment?
- Consider the pros and cons of all of your options and ask your healthcare provider about AUBAGIO.
- LEARN WHAT You MAY EXPECT WHEN STARTING ONCE-DAILY AUBAGIO
- What side effects are deal-breakers for me?
- If you’re going to live with your treatment, you need to be able to manage the side effects.
- HEAR WHAT PEOPLE ON AUBAGIO SAID ABOUT SIDE EFFECTS
- What are the main goals I want to reach with a relapsing MS treatment?
- What do you hope to achieve by starting a new treatment? Consider your expectations.
- LEARN ABOUT WHY PEOPLE CHOOSE AUBAGIO
Wherever you are in your relapsing MS journey,
Wherever you are in your relapsing MS journey,
taking stock of your MS and how it is affecting you can help you decide what’s working and what isn’t. To take a snapshot of your MS, download this handy SYMPTOM TRACKER, “My MS Fingerprint.”
“My previous treatment wasn’t working for me. That’s why I asked myself those important questions. The answers led to the right treatment for me—AUBAGIO.”
On AUBAGIO 14 mg •
Individual experiences may vary.
“I was looking for an effective treatment that meets my needs, and at the same time with side effects I could manage. For me that was AUBAGIO.”
On AUBAGIO 14 mg •
Individual experiences may vary.
Once you’ve decided what’s
important to you in a treatment,
make an appointment to talk about it with your healthcare provider, and ask about AUBAGIO, a once-daily pill that may help put relapsing MS in the background. To help with that conversation, take a look at our Doctor Discussion Guide.
VIEW THE DOCTOR DISCUSSION GUIDE
INDICATION
AUBAGIO® (teriflunomide) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
IMPORTANT SAFETY INFORMATION
DO NOT TAKE AUBAGIO IF YOU:- Have severe liver problems. AUBAGIO may cause serious liver problems, which can be life-threatening. Your risk may be higher if you take other medicines that affect your liver. Your healthcare provider should do blood tests to check your liver within 6 months before you start AUBAGIO and monthly for 6 months after starting AUBAGIO. Tell your healthcare provider right away if you develop any of these symptoms of liver problems: nausea, vomiting, stomach pain, loss of appetite, tiredness, yellowing of your skin or whites of your eyes, or dark urine.
- Are pregnant. AUBAGIO may harm an unborn baby. You should have a pregnancy test before starting AUBAGIO. After stopping AUBAGIO, continue to use effective birth control until you have made sure your blood levels of AUBAGIO are lowered. If you become pregnant while taking AUBAGIO or within 2 years after stopping, tell your healthcare provider right away and enroll in the AUBAGIO Pregnancy Registry at 1‑800‑745‑4447, option 2.
- Are pregnant. AUBAGIO may harm an unborn baby. You should have a pregnancy test before starting AUBAGIO. After stopping AUBAGIO, continue to use effective birth control until you have made sure your blood levels of AUBAGIO are lowered. If you become pregnant while taking AUBAGIO or within 2 years after stopping, tell your healthcare provider right away and enroll in the AUBAGIO Pregnancy Registry at 1-800-745-4447, option 2.
-
Are of childbearing potential and not using effective birth control.
It is not known if AUBAGIO passes into breast milk. Your healthcare provider can help you decide if you should take AUBAGIO or breastfeed — you should not do both at the same time.
If you are a man whose partner plans to become pregnant, you should stop taking AUBAGIO and talk with your healthcare provider about reducing the levels of AUBAGIO in your blood. If your partner does not plan to become pregnant, use effective birth control while taking AUBAGIO.
- Have had an allergic reaction to AUBAGIO or a medicine called leflunomide.
- Take a medicine called leflunomide for rheumatoid arthritis.
AUBAGIO may stay in your blood for up to 2 years after you stop taking it. Your healthcare provider can prescribe a medicine that can remove AUBAGIO from your blood quickly.
Before taking AUBAGIO, talk with your healthcare provider if you have: liver or kidney problems; a fever or infection, or if you are unable to fight infections; numbness or tingling in your hands or feet that is different from your MS symptoms; diabetes; serious skin problems when taking other medicines; breathing problems; or high blood pressure. Your healthcare provider will check your blood cell count and TB test before you start AUBAGIO. Talk with your healthcare provider if you take or are planning to take other medicines (especially medicines for treating cancer or controlling your immune system), vitamins or herbal supplements.
AUBAGIO may cause serious side effects, including: reduced white blood cell count — this may cause you to have more infections; numbness or tingling in your hands or feet that is different from your MS symptoms; allergic reactions, including serious skin problems; breathing problems (new or worsening); and high blood pressure. Patients with low white blood cell count should not receive certain vaccinations during AUBAGIO treatment and 6 months after.
Tell your doctor if you have any side effect that bothers you or does not go away.
The most common side effects when taking AUBAGIO include: headache; diarrhea; nausea; hair thinning or loss; and abnormal liver test results. These are not all the side effects of AUBAGIO. Tell your healthcare provider about any side effect that bothers you.
Consult your healthcare provider if you have questions about your health or any medications you may be taking, including AUBAGIO.
Please click here for full Prescribing Information, including boxed WARNING and Medication Guide.
IMPORTANT SAFETY INFORMATION
Do not take AUBAGIO if you have severe liver problems. AUBAGIO may cause serious liver problems, which can be life-threatening. Your risk may be higher if you take other medicines that affect your liver. View More